Clinical trial
Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated…
NCT00402480 · Duke University, Other · Completed
Key facts
| NCT number | NCT00402480 |
|---|---|
| Title | Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity |
| Official title | Effects of Hydroxyurea on the Prevention of Primary Stroke in Children With Sickle Cell Anemia and Elevated Transcranial Doppler (TCD) Flow Velocity |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | Hydroxyurea |
| Enrollment | 50 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Nov 22, 2006 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: